2/28
07:37 am
gpcr
Structure Therapeutics Inc. (NASDAQ: GPCR) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
High
Report
Structure Therapeutics Inc. (NASDAQ: GPCR) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
2/28
07:37 am
gpcr
Structure Therapeutics Inc. (NASDAQ: GPCR) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
High
Report
Structure Therapeutics Inc. (NASDAQ: GPCR) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
2/28
07:04 am
gpcr
Rating for GPCR
High
Report
Rating for GPCR
2/28
07:04 am
gpcr
Rating for GPCR
High
Report
Rating for GPCR
2/27
04:41 pm
gpcr
Structure Therapeutics initiated with an Outperform at William Blair
Medium
Report
Structure Therapeutics initiated with an Outperform at William Blair
2/27
04:41 pm
gpcr
Structure Therapeutics initiated with an Outperform at William Blair
Medium
Report
Structure Therapeutics initiated with an Outperform at William Blair
1/8
07:54 am
gpcr
Structure Therapeutics Inc. (NASDAQ: GPCR) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $50.00 price target on the stock.
Medium
Report
Structure Therapeutics Inc. (NASDAQ: GPCR) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $50.00 price target on the stock.
1/8
07:54 am
gpcr
Structure Therapeutics Inc. (NASDAQ: GPCR) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $50.00 price target on the stock.
Medium
Report
Structure Therapeutics Inc. (NASDAQ: GPCR) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $50.00 price target on the stock.
1/8
05:07 am
gpcr
Rating for GPCR
Low
Report
Rating for GPCR
1/7
04:15 pm
gpcr
Structure Therapeutics initiated with a Buy at Stifel
Low
Report
Structure Therapeutics initiated with a Buy at Stifel